LMNA and mandibuloacral dysplasia with type A lipodystrophy: Thus, not only the rapamycin effects on prelamin A levels here reported, but also the direct or possibly lamin-mediated effects of the drug on mTOR activity, a master regulator of the aging process [48], indicate rapamycin as a powerful therapeutic tool for MADA and other progeroid diseases.